China Universal Asset Management Company’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53K | Buy |
21,639
+251
| +1% | +$615 | 0.01% | 414 |
|
|
2025
Q1 | $143K | Buy |
21,388
+2,059
| +11% | +$13.7K | 0.01% | 338 |
|
|
2024
Q4 | $243K | Buy |
19,329
+1,824
| +10% | +$22.9K | 0.02% | 314 |
|
|
2024
Q3 | $323K | Buy |
17,505
+6,839
| +64% | +$126K | 0.04% | 263 |
|
|
2024
Q2 | $230K | Sell |
10,666
-6,699
| -39% | -$144K | 0.03% | 222 |
|
|
2024
Q1 | $468K | Buy |
17,365
+6,941
| +67% | +$187K | 0.06% | 188 |
|
|
2023
Q4 | $312K | Buy |
10,424
+8,356
| +404% | +$250K | 0.06% | 173 |
|
|
2023
Q3 | $42.4K | Buy |
2,068
+1,014
| +96% | +$20.8K | 0.01% | 239 |
|
|
2023
Q2 | $20.9K | Sell |
1,054
-21
| -2% | -$417 | 0.01% | 264 |
|
|
2023
Q1 | $18.4K | Buy |
1,075
+306
| +40% | +$5.24K | 0.01% | 228 |
|
|
2022
Q4 | $15K | Buy |
769
+151
| +24% | +$2.96K | 0.01% | 197 |
|
|
2022
Q3 | $10K | Buy |
+618
| New | +$10K | ﹤0.01% | 208 |
|